PlusDental
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Total Raised
$87.91MInvestors Count
13Deal Terms
2PlusDental Funding, PlusDental Valuation & PlusDental Revenue
6 Fundings
PlusDental's latest funding round was a Acquired for on May 20, 2022.
PlusDental's valuation in May 2020 was $110.54M.
PlusDental's latest post-money valuation is from May 2022.
Sign up for a free trial to see PlusDental's valuations in May 2022 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
5/20/2022 | Acquired | 1 | ||||
3/25/2021 | Series C - II | |||||
12/1/2020 | Unattributed VC | |||||
5/28/2020 | Series C | $110.54M | ||||
1/22/2019 | Series B |
Date | 5/20/2022 | 3/25/2021 | 12/1/2020 | 5/28/2020 | 1/22/2019 |
---|---|---|---|---|---|
Round | Acquired | Series C - II | Unattributed VC | Series C | Series B |
Amount | |||||
Investors | |||||
Valuation | $110.54M | ||||
Revenue | |||||
Sources | 1 |
PlusDental Deal Terms
2 Deal Terms
PlusDental's deal structure is available for 2 funding rounds, including their Acquired from May 20, 2022.
Round | Acquired | Series C |
---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acquired | |||||||||||||||
Series C |
PlusDental Investors
13 Investors
PlusDental has 13 investors. Straumann invested in PlusDental's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
5/20/2022 | 5/20/2022 | 1 Acquired | Corporation | Switzerland | ||
1/22/2019 | 3/25/2021 | 3 Series B, Series C (2020), Series C - II (2021) | Venture Capital | Switzerland | ||
12/1/2020 | 3/25/2021 | 2 Unattributed VC, Series C - II (2021) | Growth Equity | Germany | ||
Corporate Venture | Hong Kong | |||||
Venture Capital | Germany |
First funding | 5/20/2022 | 1/22/2019 | 12/1/2020 | ||
---|---|---|---|---|---|
Last Funding | 5/20/2022 | 3/25/2021 | 3/25/2021 | ||
Investor | |||||
Rounds | 1 Acquired | 3 Series B, Series C (2020), Series C - II (2021) | 2 Unattributed VC, Series C - II (2021) | ||
Board Seats | |||||
Type | Corporation | Venture Capital | Growth Equity | Corporate Venture | Venture Capital |
Location | Switzerland | Switzerland | Germany | Hong Kong | Germany |
You May Also Like

Candid provides clear aligners directly to customers for less than traditional in-office teeth-straightening solutions. The company's process begins when customers purchase a Modeling Kit to take impressions of their smiles in the convenience of their own home and return the Kit for assessment and modeling. The company's network of orthodontists then designs, reviews, and implements a treatment plan, with the support of the company's customer service.
Twice is a developer of oral care products.
3D Predict is a clear aligner manufacturer, leveraging artificial intelligence that predictably helps treat all cases of complexity. The company's Unique Deep CBCT Analysis allows the predictable and safe movement of teeth within the bone and avoids anatomically impossible movements, such as root collision.

Dandy is a dental technology company that focuses on improving day-to-day services for dental professionals and patients alike. It offers Labs, a free digital platform for dentists that provides them with technology and tools to be more efficient, accurate, and profitable while improving the patient experience.

Formlabs designs and manufactures 3D printing systems for engineers, designers, and artists.
3DBio is a 3D bioprinting company focused on creating personalized living tissue implants.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.